Enterotype Bacteroides Is Associated with a High Risk in Patients with Diabetes: A Pilot Study
Open accessThe DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Abstract
Background. More and more studies focus on the relationship between the gastrointestinal microbiome and type 2 diabetes, but few of them have actually explored the relationship between enterotypes and type 2 diabetes. Materials and Methods. We enrolled 134 patients with type 2 diabetes and 37 nondiabetic controls. The anthropometric and clinical indices of each subject were measured. Fecal samples of each subject were also collected and were processed for 16S rDNA sequencing. Multiple logistic regression analysis was used to determine the associations of enterotypes with type 2 diabetes. Multiple linear regression analysis was used to explore the relationship between lipopolysaccharide levels and insulin sensitivity after adjusting for age, BMI, TG, HDL-C, DAO, and TNF- α . The correlation analysis between factors and microbiota was identified using Spearman correlation analysis. The correlation analysis between factors was identified using partial correlation analysis. Results. Gut microbiota in type 2 diabetes group exhibited lower bacterial diversity compared with nondiabetic controls. The fecal communities from all subjects clustered into two enterotypes distinguished by the levels of Bacteroides and Prevotella. Logistic regression analysis showed that the Bacteroides enterotype was an independent risk factor for type 2 diabetes by decreasing insulin sensitivity. The levels of lipopolysaccharide and tumor necrosis factor-alpha were higher in the Bacteroides enterotype compared to the Prevotella enterotype. Partial correlation analysis showed that lipopolysaccharide was closely associated with diamine oxidase, tumor necrosis factor-alpha, and Gutt insulin sensitivity index after adjusting for multiple covariates. Furthermore, the level of lipopolysaccharide was found to be an independent risk factor for insulin sensitivity. Conclusions. We identified two enterotypes, Bacteroides and Prevotella , among all subjects . Our results showed that the Bacteroides enterotype was an independent risk factor for type 2 diabetes, which was due to increased levels of lipopolysaccharide causing decreased insulin sensitivity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“They have also proven relevant in metabolic disorders like type 2 diabetes, in which Bacteroides-dominant enterotypes are correlated with higher metabolic risk profiles compared to Prevotella-dominant types, enabling targeted preventive or therapeutic interventions.172,173”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [173]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Studies showed that the lower prevalence of phylum Bacteroidetes and increased Firmicutes/Bacteroidetes ratio was related to obesity and dyslipidemia [26, 27].”
BackgroundEnterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Self-citationA metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Self-citationMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819 · cited 2×
“Based on previous studies regarding the gut microbiota and insulin resistance [24, 25], we assumed that the ET B was associated with increased intestinal permeability, which then resulted in a higher bacterial LPS concentration in the blood.”
BackgroundGut microbiota composition correlates with diet and health in the elderly
Claesson, M. J., Jeffery, I. B., Conde, S., Power, S. E., O’Connor, E. M., Cusack, S., Harris, H. M. B., Coakley, M., Lakshminarayanan, B., O’Sullivan, O., et al. (2012) · Nature · doi:10.1038/nature11319 · Cited by 3,314
Gut metagenome in European women with normal, impaired and diabetic glucose control
Karlsson, F. H., Tremaroli, V., Nookaew, I., Bergström, G., Behre, C. J., Fagerberg, B., Nielsen, J., & Bäckhed, F. (2013) · Nature · doi:10.1038/nature12198 · Cited by 3,115 · cited 1×
“Many studies revealed that the microbiome of type 2 diabetic patients is characterized by an enrichment in several opportunistic pathogens [2], sulphate-reducing bacteria [6, 7], and the depletion of some probiotics [8] and some butyrateproducing bacteria [2, 6, 7].”
BackgroundGut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 4×
“Diversity analysis showed that the composition of the microbiota was different between the control and T2D group, and the T2D group had lower bacterial diversity than the control group, findings that are consistent with former studies [1, 2].”
BackgroundResultInfluentialTurnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., et al. (2015) · Nature · doi:10.1038/nature15766 · Cited by 2,116
Self-citationCorrect Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Levy, J. C., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,013
Kovatcheva-Datchary, P., Nilsson, A., Akrami, R., Lee, Y. S., De Vadder, F., Arora, T., Hallen, A., Martens, E., Björck, I., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.001 · Cited by 1,731
Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., Possemiers, S., Van Holle, A., François, P., de Vos, W. M., et al. (2011) · Diabetes · doi:10.2337/db11-0227 · Cited by 1,076
Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance
Zhang, X., Shen, D., Fang, Z., Jie, Z., Qiu, X., Zhang, C., Chen, Y., & Ji, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071108 · Cited by 946 · cited 1×
“muciniphila, in diabetic and glucose-intolerant patients [15].”
Dynamics and associations of microbial community types across the human body
Ding, T., & Schloss, P. D. (2014) · Nature · doi:10.1038/nature13178 · Cited by 885
Ussar, S., Griffin, N. W., Bezy, O., Fujisaka, S., Vienberg, S., Softic, S., Deng, L., Bry, L., Gordon, J. I., & Kahn, C. R. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.007 · Cited by 533
Molecular Characterisation of the Faecal Microbiota in Patients with Type II Diabetes
Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., Yu, P., Zhao, C., Li, L., Zhou, A., et al. (2010) · Current Microbiology · doi:10.1007/s00284-010-9582-9 · Cited by 462
Self-citationSato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., Komiya, K., Kawaguchi, M., Shimizu, T., Ogihara, T., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2817 · Cited by 437
Metagenome Sequencing of the Hadza Hunter-Gatherer Gut Microbiota
Rampelli, S., Schnorr, S. L., Consolandi, C., Turroni, S., Severgnini, M., Peano, C., Brigidi, P., Crittenden, A. N., Henry, A. G., & Candela, M. (2015) · Current Biology · doi:10.1016/j.cub.2015.04.055 · Cited by 399 · cited 1×
“found that the functional repertoire of Prevotella was linked to an increased capacity of the gut microbiota to ferment complex polysaccharides from the diet [29].”
BackgroundComparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals
Sedighi, M., Razavi, S., Navab-Moghadam, F., Khamseh, M. E., Alaei-Shahmiri, F., Mehrtash, A., & Amirmozafari, N. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.08.038 · Cited by 304
Roager, H. M., Licht, T. R., Poulsen, S. K., Larsen, T. M., & Bahl, M. I. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.03549-13 · Cited by 194
Exploration of bacterial community classes in major human habitats
Zhou, Y., Mihindukulasuriya, K. A., Gao, H., La Rosa, P. S., Wylie, K. M., Martin, J. C., Kota, K., Shannon, W. D., Mitreva, M., Sodergren, E., et al. (2014) · Genome Biology · doi:10.1186/gb-2014-15-5-r66 · Cited by 149
Yamaguchi, Y., Adachi, K., Sugiyama, T., Shimozato, A., Ebi, M., Ogasawara, N., Funaki, Y., Goto, C., Sasaki, M., & Kasugai, K. (2016) · Digestion · doi:10.1159/000447690 · Cited by 118
Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus
Sohail, M. U., Althani, A., Anwar, H., Rizzi, R., & Marei, H. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9631435 · Cited by 99
Response of gut microbiota in type 2 diabetes to hypoglycemic agents
Zhang, F., Wang, M., Yang, J., Xu, Q., Liang, C., Chen, B., Zhang, J., Yang, Y., Wang, H., Shang, Y., et al. (2019) · Endocrine · doi:10.1007/s12020-019-02041-5 · Cited by 92
Further analysis reveals new gut microbiome markers of type 2 diabetes mellitus
Wang, X., Xu, X., & Xia, Y. (2016) · Antonie van Leeuwenhoek · doi:10.1007/s10482-016-0805-3 · Cited by 38
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes
Huda, M. N., Kim, M., & Bennett, B. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632335 · Cited by 142
Buhaș, M. C., Gavrilaș, L. I., CANDREA, A. R., Cătinean, A., Mocan, A., Miere, D., & Tataru, A. D. (2022) · Nutrients · doi:10.3390/nu14142970 · Cited by 145
Gut Microbiota May Mediate the Influence of Periodontitis on Prediabetes
Li, L., Bao, J., Chang, Y.-T., Wang, M., Chen, B., & Yan, F. (2021) · Journal of Dental Research · doi:10.1177/00220345211009449 · Cited by 99
Self-citationQue, Y., Cao, M., He, J., Zhang, Q., Chen, Q., Yan, C., Lin, A., Yang, L., Wu, Z., Zhu, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.722206 · Cited by 98
A systematic review on gut microbiota in type 2 diabetes mellitus
Chong, S., Lin, M., Chong, D., Jensen, S. O., & Lau, N. S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1486793 · Cited by 127
Metadata
- Authors
- Wang, J., Li, W., Wang, C., Wang, L., He, T., Hu, H., Song, J., Cui, C., Qiao, J., Qing, L., Li, L., Zang, N., Wang, K., Wu, C., Qi, L., Ma, A., Zheng, H., Hou, X., Liu, F., & Chen, L.
- Affiliations
- Shandong University (CN)
- Department of Endocrinology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China
- Corresponding author
- Liu, Fuqiang
- Chen, Li
- ORCID
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2020-01-22
- Volume
- 2020
- Pages
- 1-11
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- PMC
- PMC6996672
- OpenAlex
- W3001325036
- Cited by
- 103
- References
- 30
- Citations by year
- 2026: 8 · 2025: 20 · 2024: 19 · 2023: 17 · 2022: 19 · 2021: 17 · 2020: 3
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Diabetes Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Taishan Scholars Project (ts201712089, 2018YFC1311801, 2016YFC0901204, 81400814, 81770818, 81873632, 81670706)
- National Key Research and Development Program of China (ts201712089, 2018YFC1311801, 2016YFC0901204, 81400814, 81770818, 81873632, 81670706)
- National Natural Science Foundation of China (ts201712089, 2018YFC1311801, 2016YFC0901204, 81400814, 81770818, 81873632, 81670706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- enterotypes, type 2 diabetes, gut microbiota, Bacteroides, Prevotella, lipopolysaccharide, insulin sensitivity, TNF-α, diamine oxidase, bacterial diversity, gut dysbiosis
- MeSH terms
- Bacillota, Gastrointestinal Microbiome, Aged, Bacteroides, Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Amine Oxidase (Copper-Containing), Humans, Insulin, Insulin Resistance, Lipopolysaccharides, Cholesterol, HDL, Male, Middle Aged, Pilot Projects, Risk Factors, RNA, Ribosomal, 16S, Triglycerides, Tumor Necrosis Factor-alpha, Logistic Models, Case-Control Studies, Prevotella, Postprandial Period, Proteobacteria, Actinobacteria, Bacteroidetes, Biodiversity, Fusobacteria, Verrucomicrobia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.